Biotech Stock News (AVXL) (BIIB) (LLY) (SPHS) (KBIO)

Anavex Life Sciences (NASDAQ:AVXL) On November 9, 2015 Anavex reported positive phase 2a results for the trial treating patients with Alzheimer’s. This trial tested two clinical endpoints. The first clinical endpoint was testing for safety as it is customary with all phase 2a trials. The second endpoint was looking for preliminary clinical efficacy. In terms … Read more

Biotech Stock News (NYMX) (GALE) (SGYP)

Nymox Pharmaceutical (NASDAQ:NYMX) On July 27, 2015 Nymox surged as high as 100% after the company reported positive phase 3 results for its BPH study. BPH stands for benign prostatic hyperplasia, and is characterized by an enlarged prostate gland. This enlarged prostate gland causes problems such as problems of urinating or the need to urinate … Read more